karuna deal

Discussion in 'Bristol-Myers Squibb' started by anonymous, Jan 16, 2024 at 3:59 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    This ^^^^^^ is 100% the BMS way.
     

  2. anonymous

    anonymous Guest

    Yep Karuna range is 150-180. No room for these laid off hacking trolls on here.
     
  3. anonymous

    anonymous Guest

    Have fun at BMS! Welcome! Its a dream come true for all of us.
     
  4. anonymous

    anonymous Guest

    Dude you are obviously butt hurt from BMS and that’s ok. You can have your pity parties on here all day if that’s your therapy. However, these Karuna packages are in a different league than you were in when you got waxed from company. We’talking 250k annual comp packages so stop being a speed bump with it all. It’s coming and will effortlessly run right over your buttt hurt self.
     
  5. anonymous

    anonymous Guest

    Anyone move past the screening interview yet
     
  6. anonymous

    anonymous Guest

    my recruiter told me they are to taking apps for two weeks. So that means the window should close today. I guess that the depends on the territory, and if there's good viable candidates to pick from.
     
  7. anonymous

    anonymous Guest

    Come on now. This is now in the hands of BMS. Nobody knows anything.
     
  8. anonymous

    anonymous Guest

    Sorry DUDE. Its now a BMS launch. If it was still Karuna it would be exciting. I am beyond butt hurt I am still here. C2C cruising into retirement soon.
     
  9. anonymous

    anonymous Guest

    Are the territories going to be single rep or pods?
     
  10. anonymous

    anonymous Guest

    A combination
     
  11. anonymous

    anonymous Guest

    Here is some advice. I only come here if you absolutely need a job.
     
  12. anonymous

    anonymous Guest

    Nobody cares about your personal situation. Go cry to your wife or somebody may give a shit. Good luck with that pal.
     
  13. anonymous

    anonymous Guest

    The Karuna product will be first in a new class. Total game changer. Company will pay.
     
  14. anonymous

    anonymous Guest

    The problem is a niche branded drug in a small schizophrenia market space with big goals because the company bought it for a stupid amount of money. Then they will sell the drug again, because the launch will fail and you all will be out of jobs. Being real I have seen this over and over at this company.
     
  15. anonymous

    anonymous Guest

    it's a tough sell because your patients literally don't want the drug
     
  16. anonymous

    anonymous Guest

    So true. This will be such a hard sell. I have 15 years of Psych experience. Asked docs. No interest..
     
  17. anonymous

    anonymous Guest

    You are laughable, get over your self absorption. You have zero influence over anyone or anything. You can’t get out of your own way. Thanks for the laughs at the expense of yourself.
     
  18. anonymous

    anonymous Guest

    BID Schizophrenia drug? Holy F..First in class. Who cares??
    Try impossible to get patients to take. Patients wont even take one pill a day and care givers dont want this
     
  19. anonymous

    anonymous Guest

    I have worked in neuro-psych for decades and I can tell you with very high confidence that docs will not prescribe this drug.

    This will go down as one of the worst corporate acquisitions of all time.
     
  20. anonymous

    anonymous Guest

    Agreed. The other indications might be ok. The reps that launch will be long gone by the time those come to fruition. BMS is making a lot of poor purchases that they will never break even on. Really odd to follow this company over the past decade to what its become now. BMY stock is in the shitter. They truly have nothing. Why would anyone purchase BMY stock?